Products for Research Use Only

Fulipiftide

CAT: 0804-HY-P10953-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10953-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fulipiftide is a short peptide derived from pigment epithelium-derived factor (PEDF) . Fulipiftide induces the expansion of nuclear stem cell factor +TSPC by activating ERK2 and STAT3 signaling pathways. Fulipiftide has anti-inflammatory activity and can be used in the study of acute tendon injury[1][2].
CAS Number
2868985-56-0
Product Name Alternative
PSP 29-mer, anti-inflammatory peptide
UNSPSC
12352209
Target
ERK; STAT
Related Pathways
JAK/STAT Signaling; MAPK/ERK Pathway; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.38
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C[C@@H](O)[C@@H](C(N)=O)NC(CNC([C@H](CC1=CN=CN1)NC([C@H]([C@@H](C)CC)NC([C@H](CC(O)=O)NC([C@H]2N(CCC2)C([C@H](CO)NC([C@H](CO)NC([C@H]([C@@H](C)CC)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@@H](NC([C@@H](NC([C@H](CC(C)C)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@@H](NC([C@H]([C@@H](C)CC)NC([C@H]([C@@H](C)CC)NC([C@H](CO)NC([C@H](CCC(O)=O)NC([C@H]([C@H](O)C)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](CCC(O)=O)NC([C@H](C)NC(CNC([C@H](CC(C)C)NC([C@H](CO)NC(C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)CC5=CC=C(C=C5)O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C144H227N41O47
Molecular Weight
3284.59
References & Citations
[1]WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38 , No. 4, 2024.|[2]Ho TC, et al. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells. Stem Cell Res Ther. 2019 Jan 3;10 (1) :2.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
ERK2; STAT3

Alternative Products